Short bursts of oxygen deprivation could help treat depression: Chinese study
Brief, controlled bouts of oxygen deprivation – essentially moments of safe suffocation – can alleviate severe depression as…
There are more than 100 autoimmune diseases, and they mostly strike women. Here’s what to know
Our immune system has a dark side: It’s supposed to fight off invaders to keep us healthy. But…
JMIR Article Argues Misapplied Pharmaceutical Model Prevents Scaling of Effective Interventions
Newswise — (Toronto, October 28, 2025) JMIR Publications today released a new article in its growing “News &…
FDA approves new menopause drug without hormones. Here’s what to know.
The U.S. Food and Drug Administration has approved Lynkuet, a new daily pill from Bayer that provides a…
New Guides: Understanding Dementia Risk, Genetics, Diagnosis in Communities of Color
Is an Alzheimer’s clinical trial right for you? What does it mean to enroll in an Alzheimer’s clinical…
Common opioid is not that effective for easing chronic pain, study finds
Tramadol, a potent synthetic opioid, has been widely used to treat moderate to severe pain, but a new…
FDA rejects Rexulti-Zoloft combo for PTSD
The FDA rejected Otsuka and Lundbeck’s Rexulti and Zoloft combination treatment for PTSD, months after raising concerns about…
Draghi had a plan to save Europe’s economy. We’ve rated it, a year in – POLITICO
Joint debt: Let’s see Draghi has been a consistent advocate for EU joint borrowing of the kind carried…
Double trouble: gene-regulating duo shapes cell fate and disease
Newswise — CLEVELAND—Shedding light on what determines how cells become what they are meant to be—nerves, bone, muscles,…
Lessons for Parkinson’s From MS, and Vice Versa
This transcript has been edited for clarity. Indu Subramanian, MD: Hi, everyone. Welcome to Medscape. I’m so excited…
Rectal Cancer Survival Not Tied to pCR
TOPLINE: According to a meta-analysis of randomized clinical trials (RCTs), pathologic complete response (pCR) was not associated with…
First New PTSD Drug in Two Decades On the Horizon?
The Psychopharmacologic Drugs Advisory Committee of the FDA is set to meet on July 18 to consider a…